<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report two cases of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus reactivation following allogeneic bone marrow transplantation (BMT) for severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The presence of antibodies to HBsAg, HBeAg and HBcAg prior to transplant indicated previous <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus (HBV) </plain></SENT>
<SENT sid="2" pm="."><plain>These antibodies disappeared 2 and 4 months after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> (GVHD) following immunosuppressive treatment, but HBsAg reappeared in their sera 6 and 10 months later, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>This suggests that <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD and immunosuppressive drugs can reactivate HBV in HBsAb-positive patients, most likely because of the decrease in quality and function of helper T cells and B cells during <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD to induce clearance of HBV antibodies and reactivation of HBV </plain></SENT>
<SENT sid="4" pm="."><plain>Our observation confirms that patients with HBsAb, HBeAb and HBcAb present in their sera should not be considered to have 'immunity' to HBV after BMT </plain></SENT>
</text></document>